Prosight Management’s Cellectis CLLS Stock Holding History

Prosight Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-87,103	Closed	-$1.1M	–	41
2021 Q3	$1.1M	Buy	87,103 +1,067	+1%	+$14.8K	0.6%	35
2021 Q2	$1.33M	Sell	86,036 -51,864	-38%	-$872K	0.83%	29
2021 Q1	$2.79M	Buy	+137,900	New	+$3.41M	2.28%	17
2020 Q4	–	Sell	-185,180	Closed	-$3.43M	–	45
2020 Q3	$3.43M	Sell	185,180 -91,397	-33%	-$1.62M	1.63%	25
2020 Q2	$4.92M	Buy	+276,577	New	+$4.21M	2.11%	20
2018 Q3	–	Sell	-19,388	Closed	-$548K	–	33
2018 Q2	$548K	Buy	+19,388	New	+$577K	0.4%	29

Other funds holding CLLS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Prosight Management's CLLS Position: Q4 2021 in Review

Prosight Management sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 87,103 shares — an estimated $1.1M sold.

Prosight Management first reported a position in CLLS in Q2 2018 and held it in 6 quarters. The position peaked at $4.92M in Q2 2020. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

Prosight Management reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
Prosight Management sold 87,103 Cellectis shares in Q4 2021, an estimated $1.1M.
Prosight Management first reported a position in Cellectis in Q2 2018 and held it in 6 quarters.
Prosight Management's Cellectis position peaked at $4.92M in Q2 2020.
57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on Prosight Management's 13F filing for Q4 2021, filed 14 Feb 2022.